https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7012 Sat 24 Mar 2018 08:38:05 AEDT ]]> Australia's pharmaceutical cost sharing policy: reducing waste or affordability ? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7008 Sat 24 Mar 2018 08:37:49 AEDT ]]> Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10528 Sat 24 Mar 2018 08:13:58 AEDT ]]> Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16505 Sat 24 Mar 2018 08:04:17 AEDT ]]> The PBS in a globalised world: free trade and reference pricing. https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16489 Sat 24 Mar 2018 08:01:53 AEDT ]]> Cost of medications for older women https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5662 Sat 24 Mar 2018 07:44:04 AEDT ]]> Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29544 Sat 24 Mar 2018 07:33:10 AEDT ]]>